Neu5Acα(2-6)Galβ(1-4)GlcNAcβ(1-2)Manα(1-3)[NeuAcα(2-6)Galβ(1-4)GlcNAcβ(1-2)Manα(1-6)]Manβ(1-4)GlcNAcβ(1-4)GlcNAc-β-Ahx-Biotin
6-tri-O-acetyl-2-deoxy-α-D-galactopyranosyl)-L-threonine
displaying multivalent α2-6 sialosides that are ligands for Siglecs and human-type influenza hemagglutinin
Cys is conjugated at the N-terminal of peptide sequence
GP100082: Cys-MUC1(126-145)-Tn(130,131,139,140,144) Pack Size:1 mg Neu5Acα(2-6)Galβ(1-4)GlcNAcβ(1-2)Manα(1-3)[NeuAcα(2-6)Galβ(1-4)GlcNAcβ(1-2)Manα(1-6)]Manβ(1-4)GlcNAcβ(1-4)GlcNAc-β-Ahx-BiotinC123H198N32O53S 3005. 14 MUC1 (UniProt ID P15941) synthetic glycopeptide fragment (Pro126 Arg145; UniProt position 126 145, aa length 20) from the tandem repeat (TR) region of the MUC1 protein. The fragment contains tumour associated carbohydrate antigen (TACA), Tn antigen, O glycosylation ( GalNAc) at Ser130, Thr131, Thr139, Ser140 and Thr144. Cys is conjugated at the N terminal of peptide sequence. The C terminus is an amide. Cys MUC1(126 145)